Results 21 to 30 of about 156,390 (266)

LncRNA-mediated regulation of cell signaling in cancer

open access: yesOncogene, 2017
To date, a large number of long non-coding RNAs (lncRNAs) have been recently discovered through functional genomics studies. Importantly, lncRNAs have been shown, in many cases, to function as master regulators for gene expression and thus, they can play
Wan-Xin Peng, Pratirodh Koirala, Y. Mo
semanticscholar   +1 more source

Construction of the seven-lncRNA-based prognostic model from ceRNA network to predict resistance to cancer drugs.

open access: yes, 2021
(A) Risk score distribution in patients with NSCLC, survival status in different groups, and heatmap of the expression of seven lncRNAs. (B) K–M plot represents that patients in the high-risk group had significantly shorter OS than those in the low-risk ...
Jie-Tao Lin (9377048)   +10 more
core   +1 more source

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma

open access: yesFrontiers in Immunology, 2021
Ferroptosis is an iron-dependent cell death process that plays important regulatory roles in the occurrence and development of cancers, including hepatocellular carcinoma (HCC).
Zhijie Xu   +10 more
semanticscholar   +1 more source

DataSheet_1_Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma.pdf

open access: yes, 2022
ObjectiveThis study was conducted in order to establish a long non-coding RNA (lncRNA)-based model for predicting overall survival (OS) in patients with lung adenocarcinoma (LUAD).MethodsOriginal RNA-seq data of LUAD samples were extracted from The ...
Jingnan Zhang (1793296)   +8 more
core   +1 more source

LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis

open access: yesMolecular Cancer, 2020
Long noncoding RNAs (lncRNAs) play crucial roles in tumor progression and are aberrantly expressed in various cancers. However, the functional roles of lncRNAs in breast cancer remain largely unknown.
Yiran Liang   +15 more
semanticscholar   +1 more source

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy

open access: yesNature Cell Biology, 2021
Major histocompatibility complex-I (MHC-I) presents tumour antigens to CD8+ T cells and triggers anti-tumour immunity. Humans may have 30,000–60,000 long noncoding RNAs (lncRNAs).
Gaopeng Li   +17 more
semanticscholar   +1 more source

LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities

open access: yes, 2022
Triple negative breast cancer (TNBC) represents a diverse group of cancers based on their gene expression profiles. While the current mRNA-based classification of TNBC has contributed to our understanding of the heterogeneity of this disease, whether ...
Elango, Ramesh   +8 more
core   +1 more source

Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data

open access: yesNucleic Acids Res., 2020
An updated Lnc2Cancer 3.0 (http://www.bio-bigdata.net/lnc2cancer or http://bio-bigdata.hrbmu.edu.cn/lnc2cancer) database, which includes comprehensive data on experimentally supported long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) associated
Yue Gao   +12 more
semanticscholar   +1 more source

LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.

open access: yesCancer Letters, 2021
Therapeutic effectiveness in breast cancer can be limited by the underlying mechanisms of pathogenesis, including epithelial-mesenchymal transition (EMT), cancer stem cells (CSCs) and drug resistance. Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs)
J. Venkatesh   +4 more
semanticscholar   +1 more source

TableE13-Pseudo-bulk-of-scRNA-seq-EMT-differential-lncRNA-expression-list.xlsx

open access: yes, 2022
TableE13-Pseudo-bulk-of-scRNA-seq-EMT-differential-lncRNA-expression-list ...
Adam Williams (12021065)   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy